ResMed (RMD) Reiterated at Hold by Stifel Amid Concerns Over FY28 Revenue Growth Decelerating

Fri, 02 Oct 2026 08:01:04 -0400

Stifel analyst Jonathan Block reiterated a Hold rating and $235.00 price target on ResMed (NYSE: RMD).

The analyst commented, "Our survey (n=35) focuses on GLP-1s, wearables, U.S. device market share (pre/ post potential Philips reentry), AirSense 12, and Apnimed’s AD109.For GLP-1s, we view the feedback as a relative positive for CPAP, and for now, we are softening our prior stance. Our wearables diligence is a positive for new starts, and consistent with prior work.However, we are more concerned around how market share plays out upon Philips’ eventual return. Resmed’s 91% 2026 U.S. device share is expected to step down to 87%

Form ARS RESMED INC For: Jun 30

Thu, 01 Oct 2026 16:37:00 -0400

si-local-file:///var/storage/secattach/20261001/27136670.html

Form DEFA14A RESMED INC

Thu, 01 Oct 2026 16:36:00 -0400

si-local-file:///var/storage/secattach/20261001/27136637.html

Form DEF 14A RESMED INC For: Jun 30

Thu, 01 Oct 2026 16:34:00 -0400

si-local-file:///var/storage/secattach/20261001/27136597.html

Form 4/A RESMED INC For: Sep 08 Filed by: Farrell Michael J.

Thu, 01 Oct 2026 16:29:00 -0400

si-local-file:///var/storage/secattach/20261001/27136433.html

Form 4 RESMED INC For: Aug 14 Filed by: Leong Justin

Thu, 01 Oct 2026 16:27:00 -0400

si-local-file:///var/storage/secattach/20261001/27136397.html

Form 4 RESMED INC For: Aug 14 Filed by: Rider Michael J

Thu, 01 Oct 2026 16:23:00 -0400

si-local-file:///var/storage/secattach/20261001/27136303.html

Form 4 RESMED INC For: Aug 14 Filed by: Farrell Michael J.

Thu, 01 Oct 2026 16:19:00 -0400

si-local-file:///var/storage/secattach/20261001/27136246.html

Form 4 RESMED INC For: Aug 14 Filed by: Bloomer Aaron

Thu, 01 Oct 2026 16:08:00 -0400

si-local-file:///var/storage/secattach/20261001/27135982.html

Resmed to Report First Quarter Fiscal 2027 Earnings on October 29, 2026

Thu, 01 Oct 2026 16:05:00 -0400

SAN DIEGO, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2027 on Thursday, October 29, 2026, after the New York Stock Exchange closes. Following the release, Resmed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast.

Earnings webcast details:

Location: https://investor.resmed.com
Date: Thursday, October 29, 2026
Resmed to Report First Quarter Fiscal 2027 Earnings on October 29, 2026

Thu, 01 Oct 2026 16:05:00 -0400

SAN DIEGO, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2027 on Thursday, October 29, 2026, after the New York Stock Exchange closes. Following the release, Resmed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast.

Earnings webcast details:
- Location: https://investor.resmed.com
- Date: Thursday, October 29, 2026
- CMS pumps $51M into rural Texas to fight diabetes and obesity
  
  Mon, 28 Sep 2026 10:10:24 -0400
  
  Investing.com - The federal government is deploying $51 million to 68 rural Texas hospital districts to build and expand chronic disease prevention programs targeting diabetes, cardiovascular disease, respiratory illness, and obesity, according to a CMS announcement dated September 28, 2026. The funding is the first visible tranche of Texas's $281 million first-year allocation from the $50 billion Rural Health Transformation Program (RHTP), itself established by the Working Families Tax Cuts Act.
  At roughly $750,000 per district, the individual tranche is modest on its own — but institutional investors should read it as a structural demand signal: Texas alone is slated for
  
  CMS pumps $51M into rural Texas to fight diabetes and obesity
  
  Mon, 28 Sep 2026 10:10:24 -0400
  
  Investing.com - The federal government is deploying $51 million to 68 rural Texas hospital districts to build and expand chronic disease prevention programs targeting diabetes, cardiovascular disease, respiratory illness, and obesity, according to a CMS announcement dated September 28, 2026. The funding is the first visible tranche of Texas's $281 million first-year allocation from the $50 billion Rural Health Transformation Program (RHTP), itself established by the Working Families Tax Cuts Act.
  At roughly $750,000 per district, the individual tranche is modest on its own — but institutional investors should read it as a structural demand signal: Texas alone is slated for
  
  CMS pumps $51M into rural Texas to fight diabetes and obesity
  
  Mon, 28 Sep 2026 10:10:24 -0400
  
  Investing.com - The federal government is deploying $51 million to 68 rural Texas hospital districts to build and expand chronic disease prevention programs targeting diabetes, cardiovascular disease, respiratory illness, and obesity, according to a CMS announcement dated September 28, 2026. The funding is the first visible tranche of Texas's $281 million first-year allocation from the $50 billion Rural Health Transformation Program (RHTP), itself established by the Working Families Tax Cuts Act.
  At roughly $750,000 per district, the individual tranche is modest on its own — but institutional investors should read it as a structural demand signal: Texas alone is slated for
  
  CMS pumps $51M into rural Texas to fight diabetes and obesity
  
  Mon, 28 Sep 2026 10:10:24 -0400
  
  Investing.com - The federal government is deploying $51 million to 68 rural Texas hospital districts to build and expand chronic disease prevention programs targeting diabetes, cardiovascular disease, respiratory illness, and obesity, according to a CMS announcement dated September 28, 2026. The funding is the first visible tranche of Texas's $281 million first-year allocation from the $50 billion Rural Health Transformation Program (RHTP), itself established by the Working Families Tax Cuts Act.
  At roughly $750,000 per district, the individual tranche is modest on its own — but institutional investors should read it as a structural demand signal: Texas alone is slated for
  
  CMS pumps $51M into rural Texas to fight diabetes and obesity
  
  Mon, 28 Sep 2026 10:10:24 -0400
  
  Investing.com - The federal government is deploying $51 million to 68 rural Texas hospital districts to build and expand chronic disease prevention programs targeting diabetes, cardiovascular disease, respiratory illness, and obesity, according to a CMS announcement dated September 28, 2026. The funding is the first visible tranche of Texas's $281 million first-year allocation from the $50 billion Rural Health Transformation Program (RHTP), itself established by the Working Families Tax Cuts Act.
  At roughly $750,000 per district, the individual tranche is modest on its own — but institutional investors should read it as a structural demand signal: Texas alone is slated for
  
  CMS pumps $51M into rural Texas to fight diabetes and obesity
  
  Mon, 28 Sep 2026 10:10:24 -0400
  
  Investing.com - The federal government is deploying $51 million to 68 rural Texas hospital districts to build and expand chronic disease prevention programs targeting diabetes, cardiovascular disease, respiratory illness, and obesity, according to a CMS announcement dated September 28, 2026. The funding is the first visible tranche of Texas's $281 million first-year allocation from the $50 billion Rural Health Transformation Program (RHTP), itself established by the Working Families Tax Cuts Act.
  At roughly $750,000 per district, the individual tranche is modest on its own — but institutional investors should read it as a structural demand signal: Texas alone is slated for
  
  CMS pumps $51M into rural Texas to fight diabetes and obesity
  
  Mon, 28 Sep 2026 10:10:24 -0400
  
  Investing.com - The federal government is deploying $51 million to 68 rural Texas hospital districts to build and expand chronic disease prevention programs targeting diabetes, cardiovascular disease, respiratory illness, and obesity, according to a CMS announcement dated September 28, 2026. The funding is the first visible tranche of Texas's $281 million first-year allocation from the $50 billion Rural Health Transformation Program (RHTP), itself established by the Working Families Tax Cuts Act.
  At roughly $750,000 per district, the individual tranche is modest on its own — but institutional investors should read it as a structural demand signal: Texas alone is slated for
  
  CMS pumps $51M into rural Texas to fight diabetes and obesity
  
  Mon, 28 Sep 2026 10:10:24 -0400
  
  Investing.com - The federal government is deploying $51 million to 68 rural Texas hospital districts to build and expand chronic disease prevention programs targeting diabetes, cardiovascular disease, respiratory illness, and obesity, according to a CMS announcement dated September 28, 2026. The funding is the first visible tranche of Texas's $281 million first-year allocation from the $50 billion Rural Health Transformation Program (RHTP), itself established by the Working Families Tax Cuts Act.
  At roughly $750,000 per district, the individual tranche is modest on its own — but institutional investors should read it as a structural demand signal: Texas alone is slated for
  
  CMS pumps $51M into rural Texas to fight diabetes and obesity
  
  Mon, 28 Sep 2026 10:10:24 -0400
  
  Investing.com - The federal government is deploying $51 million to 68 rural Texas hospital districts to build and expand chronic disease prevention programs targeting diabetes, cardiovascular disease, respiratory illness, and obesity, according to a CMS announcement dated September 28, 2026. The funding is the first visible tranche of Texas's $281 million first-year allocation from the $50 billion Rural Health Transformation Program (RHTP), itself established by the Working Families Tax Cuts Act.
  At roughly $750,000 per district, the individual tranche is modest on its own — but institutional investors should read it as a structural demand signal: Texas alone is slated for
  
  ResMed (RMD) call put ratio 1.5 calls to 1 put as share price up 4.3%
  
  Tue, 15 Sep 2026 13:59:06 -0400
  
  ResMed (NYSE: RMD) 30-day call option implied volatility is 28; compared to its 52-week range of 24 to 52. Call put ratio 1.5 calls to 1 put as share price up 4.3%.
  
  RBC Capital Upgrades ResMed (RMD) to Outperform
  
  Tue, 15 Sep 2026 03:58:37 -0400
  
  RBC Capital analyst Craig Wong-Pan upgraded ResMed (NYSE: RMD) from Sector Perform to Outperform with a price target of $262.00 (from $244.00).
  The analyst comments: “RMD is the market leader in OSA devices and accessories and we expect it will continue benefiting from increased awareness and penetration of the global OSA market. The company now has a greater focus on capital management, and we forecast it can achieve HSD EPS growth over the next 3 years despite our assumption of Philips Respironics returning to the US market in FY28. Given the positive earnings outlook and an undemanding valuation, we upgrade the
  
  RBC Capital Upgrades ResMed (RMD) to Outperform
  
  Tue, 15 Sep 2026 03:58:37 -0400
  
  RBC Capital analyst Craig Wong-Pan upgraded ResMed (NYSE: RMD) from Sector Perform to Outperform with a price target of $262.00 (from $244.00).
  The analyst comments: “RMD is the market leader in OSA devices and accessories and we expect it will continue benefiting from increased awareness and penetration of the global OSA market. The company now has a greater focus on capital management, and we forecast it can achieve HSD EPS growth over the next 3 years despite our assumption of Philips Respironics returning to the US market in FY28. Given the positive earnings outlook and an undemanding valuation, we upgrade the
  
  Form 4 RESMED INC For: Sep 08 Filed by: Farrell Michael J.
  
  Thu, 10 Sep 2026 06:40:00 -0400
  si-local-file:///var/storage/secattach/20260910/27044798.html
  
  Form 144 RESMED INC Filed by: Farrell Michael J.
  
  Tue, 08 Sep 2026 13:21:00 -0400
  si-local-file:///var/storage/secattach/20260908/27035779.html

StreetInsider.com News Articles

ResMed (RMD) Reiterated at Hold by Stifel Amid Concerns Over FY28 Revenue Growth Decelerating

Form ARS RESMED INC For: Jun 30

Form DEFA14A RESMED INC

Form DEF 14A RESMED INC For: Jun 30

Form 4/A RESMED INC For: Sep 08 Filed by: Farrell Michael J.

Form 4 RESMED INC For: Aug 14 Filed by: Leong Justin

Form 4 RESMED INC For: Aug 14 Filed by: Rider Michael J

Form 4 RESMED INC For: Aug 14 Filed by: Farrell Michael J.

Form 4 RESMED INC For: Aug 14 Filed by: Bloomer Aaron

Resmed to Report First Quarter Fiscal 2027 Earnings on October 29, 2026

Resmed to Report First Quarter Fiscal 2027 Earnings on October 29, 2026

CMS pumps $51M into rural Texas to fight diabetes and obesity

CMS pumps $51M into rural Texas to fight diabetes and obesity

CMS pumps $51M into rural Texas to fight diabetes and obesity

CMS pumps $51M into rural Texas to fight diabetes and obesity

CMS pumps $51M into rural Texas to fight diabetes and obesity

CMS pumps $51M into rural Texas to fight diabetes and obesity

CMS pumps $51M into rural Texas to fight diabetes and obesity

CMS pumps $51M into rural Texas to fight diabetes and obesity

CMS pumps $51M into rural Texas to fight diabetes and obesity

ResMed (RMD) call put ratio 1.5 calls to 1 put as share price up 4.3%

RBC Capital Upgrades ResMed (RMD) to Outperform

RBC Capital Upgrades ResMed (RMD) to Outperform

Form 4 RESMED INC For: Sep 08 Filed by: Farrell Michael J.

Form 144 RESMED INC Filed by: Farrell Michael J.